About PrecisionLife

Chronic diseases are the biggest challenge facing global health

Billions of people live with debilitating conditions that are misunderstood, misdiagnosed, and mistreated – costing lives, wellbeing, and trillions of dollars to global economies.

PrecisionLife is here to change that.

We use cutting-edge AI and the most advanced genetic analytics platform on the planet to uncover the biological drivers of disease that are invisible to other AI and genomic data models. Our platform reveals the unique mechanisms causing illness in individuals. This lets us:

Develop low-cost, non-invasive tests that can predict and diagnose diseases earlier and more accurately
Help doctors match patients with the most effective treatments based on their personal biology
Support pharmaceutical companies to develop smarter, more targeted therapies
Identify the hidden biology that actively protects people and prevents disease

Our approach is groundbreaking and already helping to tackle 60+ diseases across neuroscience, women's health, immunology & more.

We’ve built the world’s largest database of chronic disease insights and are working with partners across healthcare and biopharma to bring truly personalized medicine to life – improving lives and reducing the unsustainable pressure on health systems.

Our mission is bold but simple:
To give every patient a faster, clearer path to better health – creating better, more personalized treatment options and diagnostic tools to reduce the global burden of chronic disease through precision medicine that works for everyone.

A new era of precision medicine

Chronic diseases are caused by a complex interplay of multiple genes and heterogeneous factors. Their complexity means that patients with the same diagnosis may have different drivers of disease and will benefit from different therapies.

These differences cannot be understood by previous gold standard genomic analyses such as GWAS, polygenic risk scores, generative AI, or panel-based diagnostics.

Therefore, while oncology has been transformed by precision medicine, more prevalent and expensive chronic diseases have not.

Until now...

Putting people at the center of their health

We've completely reimagined how to analyze patient data.

Using our Combinatorial Analytics & AI platform we are the first company able to understand and stratify complex disease biology – identifying the mechanistic causes of disease in individual patients.

This allows us to create more personalized diagnostic tools, therapy options and clinical pathways, and to find the right patients for new trials and treatments based on biology.

Increasing success for clinical trials, treatments and patients.

Patients at center of their health (2)-min (1)

A snapshot of our progress

Driving precision medicine in complex, chronic diseases

World-leading science

10x signal from 10% of data

Our platform is world-leading – identifying causal biology, the holy grail of precision medicine, in over 60 complex diseases.

Improving global health

>5 Billion patients lives

Our clinical research studies have created new precision medicine opportunities for diseases that affect 5.4B people.

Proprietary disease insights

>100K protectable IP assets

We've created the most valuable repository of chronic disease insights, including biomarkers, risk models, and novel targets.

Rapid reduction to practice

Reducing the cost of healthcare

Our mechanostic tests identify disease risk for earlier, more personalized intervention and prevention of chronic diseases.

We're addressing one of the greatest challenges of our time – transforming healthcare to predict, treat, and prevent the world's most costly diseases.

Chronic diseases are the biggest challenge facing global health

"To truly understand, predict and prevent complex diseases, we must move beyond symptom-based labels and adopt a fundamentally mechanistic view of biology – just as we did to transform cancer care into precision medicine."

"PrecisionLife leads the world in identifying the mechanisms of disease and turning insights into clinically actionable solutions to reduce the global burden of chronic disease."